Header Logo

Connection

ALIREZA MOJTAHEDI to Neuroendocrine Tumors

Back to Details
This is a "connection" page, showing publications ALIREZA MOJTAHEDI has written about Neuroendocrine Tumors.
ALIREZA MOJTAHEDI
Connection Strength
0.073
Neuroendocrine Tumors
  1. Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: the first US phase 2 experience. Pancreas. 2014 May; 43(4):518-25.
    View in: PubMed
    Score: 0.073
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.